SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LT who wrote (1473)6/20/1998 10:37:00 AM
From: drdan  Read Replies (1) of 5402
 
Baxter,who seem to be very focused on bringing a "blood substitute" to market,now have no product and have spent a ton of money to find this out ....it MAY be that they will look at products already in various phases of testing rather than start from scratch, and pher02 happens to be one such product, with a bit of promise, I might add.....Sanguine has a good bit of leverage when it comes to dealing with these large companies, IMO, because they are one of the few companies left with a product that has a good chance of approval and widespread use...

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext